Condition: Breast Cancer · Metastatic Breast Cancer · Breast Neoplasm · Sponsor: BriaCell Therapeutics Corporation
This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor \[Retifanlimab\], versus Treatment of Patients'/Physicians' Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies available.
This description comes directly from the study's public registry record.
Sue Torchio, CPM · 267-797-2061 · sue.torchio@PrevailinfoWorks.com
Marcela Salgado, MD · 1-888-309-1868 · MSalgado@briacell.com
Always discuss trial participation with your own doctor first.
| Mayo Clinic-Comprehensive Cancer Center-Breast Clinic | Phoenix, Arizona, United States | Recruiting |
| University of Arizona-Cancer Center | Tucson, Arizona, United States | Recruiting |
| Los Angeles cancer Network_Anaheim | Anaheim, California, United States | Recruiting |
| Comprehensive Blood and Cancer Center | Bakersfield, California, United States | Recruiting |
| Cedars-Sinai Cancer Beverly Hills | Beverly Hills, California, United States | Recruiting |
| Los Angeles Cancer Network_Corona | Corona, California, United States | Recruiting |
| Los Angeles cancer Network_Fountain Vallley | Fountain Valley, California, United States | Recruiting |
| Los Angeles Cancer Network_Glendale | Glendale, California, United States | Recruiting |
| Hoag Hospital Center | Irvine, California, United States | Recruiting |
| Hoag Hospital Irvine | Irvine, California, United States | Recruiting |
| Los Angeles Cancer Network | Los Angeles, California, United States | Recruiting |
| Cedars-Sinai Cancer at Cedars-Sinai Medical Facility | Los Angeles, California, United States | Recruiting |
+ 67 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06072612